Intracellular and extracellular rhomboid shaped crystalline inclusions in a case of IgG lambda restricted plasma cell myeloma: a case report and review of the literature
© Matoso et al; licensee BioMed Central Ltd. 2010
Received: 2 September 2009
Accepted: 21 January 2010
Published: 21 January 2010
The presence of crystalline inclusions in plasma cell myeloma is a rare phenomenon and cases have been reported with rod, needle, and rectangular shaped crystals. Here, we present a case of IgG lambda restricted plasma cell myeloma with rhomboid shaped intracellular crystalline inclusions and extracellular crystal depositions in the bone marrow. Since rhomboid crystal depositions can be seen in other clinical conditions such as pseudogout, this case invites consideration of plasma cell myeloma in the differential diagnosis of patients with rhomboid crystalline deposition in the bone marrow and in sites/organs other than the bone marrow.
Plasma cell myeloma accounts for approximately one percent of all cancers and slightly more than 10 percent of hematologic malignancies in the United States . The disease stems from malignant transformation of plasma cells with frequent overproduction of immunoglobulins. Its clinical presentation with intracellular and extracellular crystalline inclusions is a rare but recognized phenomenon [2–4]. Crystalline inclusions with rod, needle, and rectangular shapes have been associated with free kappa or with IgA, IgD, IgG, and kappa light chain gammopathies [5–7]. Additionally, crystalline structures have been described in the cytoplasm of plasma cells in a patient with adult Fanconi syndrome and plasma cell myeloma . It has been determined that crystalline structures are of immunoglobulin origin and are found not only in plasma cells but also in other hematopoietic cells . Here, we present a case of IgG lambda restricted plasma cell myeloma with rhomboid intracytoplasmic crystalline inclusions and extracellular crystal deposition.
The patient is a 72 year-old male who was referred to a hematologist for work-up of anemia and leukopenia. He has had a gradual and persistent decrease in his hemoglobin levels during the past 3 years (13.6 G/DL in average; reference values 13.5-16.0 G/DL) associated with mild leukopenia (3.4 × 103/μL; reference values 3.5-11.0 × 109/L). Additionally, a year prior to the current presentation, the patient developed intermittent episodes of confusion and memory loss. The latest complete blood count was remarkable for hemoglobin of 12.1 g/dL and white blood cell count of 3.3 × 103/μL. The protein level in a 24-hour urine sample was elevated to 810 mg/24 hs (reference values 42-225 mg/24 hs). BUN and creatinine were within the normal range. Serum protein electrophoresis revealed a hypogammaglobulinemia pattern with monoclonal gamma paraprotein (0.83 g/dL). Serial radiographs of the calvarium, cervical, thoracic, lumbar spine, as well as bilateral humeri and femora did not show lytic lesions.
Due to underlying cognitive deficits a decision was made to initiate low dose lenalidomide therapy at 15 mg daily for 21 out of every 28 days. Within the first week of medical treatment the patient developed a pruritic rash on his bilateral arms which disappeared after seven days but reappeared with increasing severity and more forgetfulness with the second cycle of lenalidomide. The patient was then switched to thalidomide at 100 mg/day but due to fatigue the dose was decreased to 50 mg daily which the patient continues to tolerate well. Dexamethasone was held due to clinical concern for increasing of patient's cognitive deficits with plans of a trial if he tolerates thalidomide. His paraprotein levels stayed relatively stable with the lenalidomide, 0.83 g/dl at diagnosis to 0.81 g/dl 6 weeks later, and a mild decrease to 0.75 g/dl 4 weeks after beginning thalidomide.
Plasma cell crystalline inclusions with rod, rectangular, and needle-like shapes have been described in cases of multiple myeloma and they are believed to be due to accumulation of cytoplasmic immunoglobulins secondary to a block in the protein synthetic pathway [2, 5, 8]. Herein we present a case of plasma cell myeloma with rhomboid intracytoplasmic crystalline inclusions and extracellular crystals deposition. It is of note that it has been postulated that the presence of crystalline inclusions may indicate a nonprogressive clinical course of the disease . However, since this morphological pattern of presentation of multiple myeloma is very rare, its prognostic significance is currently largely unknown. Yet, it is important to consider this association as part of the differential diagnosis in a patient with plasma cell myeloma and, for example, arthritis with crystal deposition. Rectangular, rod-like and rhomboid-like crystals in the joints could be seen in cases of calcium pyrophosphate dihydrate (CPPD) crystal deposition disease or pseudogout. In plasma cell myeloma, a rheumatoid-like seronegative polyarticular erosive arthropathy is an unusual but reported presentation characterized by crystal deposition of cryoglobulins in the synovium and several other tissues . The patient presented here did not report articular symptoms for which we could not yet establish a connection between crystalline deposits in the bone marrow and the synovium.
Renal parenchyma damage in patients with plasma cell myeloma is frequent and well characterized and can involve crystal depositions. Renal biopsy can show intracytoplasmic crystalline inclusions most frequently located in the distal tubule, but that can also be seen in the proximal tubule . So far, the patient presented here has not suffered renal insufficiency and a renal biopsy is not available. Therefore, an association between bone marrow and renal parenchyma crystalline deposition could not be made.
The skin and subcutaneous tissue could also be a site of crystalline depositions in patients with plasma cell myeloma [11, 12]. In such cases, crystalloid structures have been identified within histiocytes and the entity interpreted as a cutaneous crystal storing histiocytosis . Interestingly, a case of bilateral ecchymoses and corneal crystal deposition have been reported as initial presentation of plasma cell myeloma in a 55 year-old man . This patient presented with amyloidosis and Bence-Jones proteins but crystalline deposits in the bone marrow were not reported.
The differential diagnosis in cases of plasma cell intracytoplasmic crystalline inclusions should also include reactive processes, since it has been shown to occur in cases of helicobacter associated gastritis . In the case presented here, a reactive process is ruled out due to the monotypic nature of the plasma cell population.
Finally, crystalline inclusions similar to those seen in plasma cell myeloma have been described in cases of granulocytic sarcoma . Electron microscopy demonstrated homogeneously dense, bipyramidal structures, similar to Charcot-Leyden crystals. Should the morphology be equivocal, immunophenotypical and molecular studies might be necessary to yield the correct diagnosis.
Of note, somewhat unusual in our patient is the clinical presentation with cognitive deficits. While this could be merely a coincidental event, a possible association with patient's myeloma cannot be completely excluded based on the current data available. Histopathological evaluation of the central nervous system and/or future case reports of similar clinical and histopathological presentations should help to understand whether such a connection exists.
In summary, this case of plasma cell myeloma with rhomboid crystalline inclusions invites review and consideration of plasma cell myeloma in cases presenting with intracytoplasmic crystalline inclusions and extracellular crystals depositions. The literature suggests that plasma cell myeloma and crystal deposition can occur in different sites such as joints, kidneys, skin and cornea in addition to bone marrow. None of the cases reported so far presented with crystal deposition in the bone marrow and in other sites.
The case presented here illustrates an unusual finding in a patient with plasma cell myeloma. This case and the review of similar cases presented in the literature suggest that extracellular rhomboid crystals in the bone marrow and extramedullary sites such as articular spaces or renal parenchyma should raise suspicion of a plasma cell neoplasm, yet other differential diagnoses such as granulocytic sarcoma or reactive processes should also be considered.
Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
- Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ: Cancer statistics, 2009. CA Cancer J Clin. 2009, 59: 225-249. 10.3322/caac.20006.View ArticlePubMedGoogle Scholar
- Patriarca C, Giunta P, Di Pasquale M, Comande M: Images in pathology. Crystalline inclusions in plasma cell myeloma. Int J Surg Pathol. 2007, 15: 301-10.1177/1066896907302360.View ArticlePubMedGoogle Scholar
- Gruszecki AC, Reddy VV: Plasma cell crystalline inclusions. Arch Pathol Lab Med. 2002, 126: 755-PubMedGoogle Scholar
- Brodie C, Agrawal S, Rahemtulla A, O'Shea D, Lampert I, Naresh KN: Multiple myeloma with bone marrow extracellular crystal deposition. J Clin Pathol. 2007, 60: 1064-1065. 10.1136/jcp.2005.034595.PubMed CentralView ArticlePubMedGoogle Scholar
- Raman SB, Van Slyck EJ: Nature of intracytoplasmic crystalline inclusions in myeloma cells (morphologic, cytochemical, ultrastructural, and immunofluorescent studies). Am J Clin Pathol. 1983, 80: 224-228.PubMedGoogle Scholar
- Gabriel L, Escribano L, Perales J, Bellas C, Odriozola J, Navarro JL: Multiple myeloma with crystalline inclusions in most hemopoietic cells. Am J Hematol. 1985, 18: 405-411. 10.1002/ajh.2830180410.View ArticlePubMedGoogle Scholar
- Jennette JC, Wilkman AS, Benson JD: IgD myeloma with intracytoplasmic crystalline inclusions. Am J Clin Pathol. 1981, 75: 231-235.PubMedGoogle Scholar
- Levine SB, Bernstein LD: Crystalline inclusions in multiple myeloma. JAMA. 1985, 254: 1985-10.1001/jama.254.14.1985.View ArticlePubMedGoogle Scholar
- Rodriguez-Paez AC, Seetharaman M, Brent LH: Cryoglobulin crystal arthropathy in a patient with multiple myeloma. J Clin Rheumatol. 2009, 15: 238-240. 10.1097/RHU.0b013e3181a567b5.View ArticlePubMedGoogle Scholar
- Kapur U, Barton K, Fresco R, Leehey DJ, Picken MM: Expanding the pathologic spectrum of immunoglobulin light chain proximal tubulopathy. Arch Pathol Lab Med. 2007, 131: 1368-1372.PubMedGoogle Scholar
- Pock L, Stuchlik D, Hercogova J: Crystal storing histiocytosis of the skin associated with multiple myeloma. Int J Dermatol. 2006, 45: 1408-1411. 10.1111/j.1365-4632.2006.02919.x.View ArticlePubMedGoogle Scholar
- Jenkins RE, Calonje E, Fawcett H, Greaves MW, Wilson-Jones E: Cutaneous crystalline deposits in myeloma. Arch Dermatol. 1994, 130: 484-488. 10.1001/archderm.130.4.484.View ArticlePubMedGoogle Scholar
- Goldstein DA, Schteingart MT, Birnbaum AD, Tessler HH: Bilateral eyelid ecchymoses and corneal crystals: an unusual presentation of multiple myeloma. Cornea. 2005, 24: 757-758. 10.1097/01.ico.0000154381.13237.a3.View ArticlePubMedGoogle Scholar
- Stewart CJ, Spagnolo DV: Crystalline plasma cell inclusions in helicobacter-associated gastritis. J Clin Pathol. 2006, 59: 851-854. 10.1136/jcp.2005.033233.PubMed CentralView ArticlePubMedGoogle Scholar
- Strauchen JA, Gordon RE: Crystalline inclusions in granulocytic sarcoma. Arch Pathol Lab Med. 2002, 126: 85-86.PubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.